Rose Bengal–Amphiphilic Peptide Conjugate for Enhanced Photodynamic Therapy of Malignant Melanoma
- 15 January 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 63 (3) , 1328-1336
Abstract
MMalignant melanoma is an aggressive skin cancer with poor survival outcomes for patients diagnosed at an advanced stage. While targeted BRAF and immune checkpoint inhibitors have improved survival outcomes for a proportion of these patients, response rates remain variable. There is a need, therefore, for more effective treatments to bolster the options available for melanoma patients. In this manuscript, we covalently attached Rose Bengal (RB) to the amphipathic peptide (AMP) C(KLAKLAK)2 and determine the effectiveness of the resulting RB-C(KLAKLAK)2 conjugate as a Photodynamic Therapy (PDT) sensitiser. RB-C(KLAKLAK)2 mediated PDT treatment of subcutaneous B16-F10-Luc2 tumours in C57 mice resulted in lesions that were 479% smaller at the end of the study than animals treated with RB mediated PDT. The synergistic effect between RB and C(KLAKLAK)2 has been attributed to the AMP sensitising cells to reactive oxygen species (ROS), making them more susceptible to ROS-induced oxidative stress.Keywords
Funding Information
- Royal Society
- Invest Northern Ireland
This publication has 28 references indexed in Scilit:
- Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in MelanomaFrontiers in Immunology, 2019
- Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and LimitationsFrontiers in Oncology, 2018
- Melanoma epidemiology, biology and prognosisEuropean Journal of Cancer Supplements, 2013
- Resistance to BRAF-targeted therapy in melanomaEuropean Journal of Cancer, 2013
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trialThe Lancet, 2012
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationNew England Journal of Medicine, 2011
- Melanocytes in development and cancerJournal of Cellular Physiology, 2009
- Photodynamic Therapy in OncologyThe Oncologist, 2006
- Cutaneous Melanoma, 4th EditionDermatologic Surgery, 2005
- A Review of Progress in Clinical Photodynamic TherapyTechnology in Cancer Research & Treatment, 2005